India's No.1 PU & Degree With Integrated IAS & IPS(UPSC/PSC) Training College.
26Oct 2024
Semaglutide May Reduce Alzheimer’s Risk in Diabetics
Why in the news? A new study suggests that semaglutide, a drug for type 2 diabetes and weight loss, may significantly reduce Alzheimer’s risk. This potential breakthrough offers a novel approach to dementia prevention alongside diabetes management, especially for high-risk populations. Study Overview and Findings: Semaglutide, the active ingredient in popular drugs for type 2 …
Read More
